The RNA vaccine developed by Moderna now has published data in the New England Journal of Medicine and will be proceeding to the next phase of trials. Dr. Seheult of also discusses compelling hypotheses about the role of von Willebrand…
The RNA vaccine developed by Moderna now has published data in the New England Journal of Medicine and will be proceeding to the next phase of trials. Dr. Seheult of also discusses compelling hypotheses about the role of von Willebrand…
Inhaled corticosteroids for the treatment of COVID-19 is a topic that has generated significant interest during this pandemic, especially after dexamethasone was shown to reduce mortality in the RECOVERY randomized controlled trials. Dr. Seheult of discusses what we know about…
There is mounting evidence that COVID-19 has a profound impact on the endothelium (the lining of blood vessels) which may explain the observed blood clots associated with this pandemic. Roger Seheult, MD of discusses new research from the Lancet on…